Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time read with Company’s Code of conduct to regulate, monitor and report the trading of equity shares. ANG Lifesciences India has informed that the trading window for dealing in the securities of the Company shall remain closed from 01 October, 2026 for the insider, designated persons of the company and their immediate relatives, till the end of 48 hours after declaration of the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on 30th September, 2026 Accordingly, all Designated Persons and their Immediate Relatives of the Company are being advised not to trade in the securities of the Company during the aforesaid period of closure of the Trading Window. The date of Board Meeting for consideration of Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30th September, 2026 shall be intimated separately.
The above information is a part of company’s filings submitted to BSE.
